Uncategorized - December 13, 2013
EU grants to three Karolinska Development companies
The portfolio companies Pergamum, Inhalation Sciences Sweden (ISS) and XSpray Microparticles have been awarded research grants totaling more than EUR 1 million. Pergamum has been allocated EUR 250,000, ISS EUR 384,000 and XSpray Microparticles EUR 401,000. The grant is within the framework of the international research project FORMAMP. The goal is to develop new ways to treat […]